Home Applications 208866 Application 208866
Type ANDA
Sponsor MACLEODS PHARMS LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RASAGILINE MESYLATE RASAGILINE MESYLATE TABLET;ORAL EQ 0.5MG BASE No No 002 RASAGILINE MESYLATE RASAGILINE MESYLATE TABLET;ORAL EQ 1MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A208866-001 RASAGILINE MESYLATE RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 A208866-002 RASAGILINE MESYLATE RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208866-001 RASAGILINE MESYLATE EQ 0.5MG BASE TABLET / ORAL AB 2024-06-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A208866-002 RASAGILINE MESYLATE EQ 1MG BASE TABLET / ORAL AB 2024-06-28 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Rasagiline RASAGILINE Macleods Pharmaceuticals Limited e8771c7e-5ecf-47dc-a0fd-4d12e85631a6 2025-08-25 Warnings, Adverse reactions Exact identifier application applno (ANDA): 208866 application number: ANDA208866